Biotechnology and Life Science Marketing Consulting: Comprendia http://comprendia.com Communicating the Business of Science Thu, 02 Jul 2009 00:00:00 +0000 http://wordpress.org/?v=2.8 en hourly 1 Johnson & Johnson to Buy $1 Billion Elan Corporation PLC Stake, Work on Alzheimer’s http://www.biospace.com/news_story.aspx?StoryID=148609&full=1 http://www.biospace.com/news_story.aspx?StoryID=148609&full=1#comments Thu, 02 Jul 2009 00:00:00 +0000 BioSpace.com Featured News tag:rss.biospace.com://4b4e09e67935db202cb589c40e95499e http://www.biospace.com/news_story.aspx?StoryID=148609&full=1/feed/ 0 Johnson & Johnson’s Named Winner of 2009 Award for Biomedical Research http://www.biospace.com/news_story.aspx?StoryID=148595&full=1 http://www.biospace.com/news_story.aspx?StoryID=148595&full=1#comments Wed, 01 Jul 2009 00:00:00 +0000 BioSpace.com Featured News tag:rss.biospace.com://eace4089f0e1d7506a946ec124262dc0 http://www.biospace.com/news_story.aspx?StoryID=148595&full=1/feed/ 0 Octagon Research Solutions, Inc. Introduces Newest Version of StartingPoint(R) http://www.biospace.com/news_story.aspx?StoryID=148594&full=1 http://www.biospace.com/news_story.aspx?StoryID=148594&full=1#comments Wed, 01 Jul 2009 00:00:00 +0000 BioSpace.com Featured News tag:rss.biospace.com://bdec9ce2dd3f47058669539a7865359f http://www.biospace.com/news_story.aspx?StoryID=148594&full=1/feed/ 0 Biotechnology Industry Organization (BIO) President & CEO to Lead Panel Discussion on Synthetic Biology and Eco-Innovation http://www.biospace.com/news_story.aspx?StoryID=148598&full=1 http://www.biospace.com/news_story.aspx?StoryID=148598&full=1#comments Wed, 01 Jul 2009 00:00:00 +0000 BioSpace.com Featured News tag:rss.biospace.com://34d7c56159e051e0323d8bab96b6870f http://www.biospace.com/news_story.aspx?StoryID=148598&full=1/feed/ 0 Six Month Clinical Outcomes of Sahajanand Medical Technologies’s Supralimus-Sirolimus Eluting Stent with a Biodegradable Polyme is presented at 2009 http://www.biospace.com/news_story.aspx?StoryID=148593&full=1 http://www.biospace.com/news_story.aspx?StoryID=148593&full=1#comments Wed, 01 Jul 2009 00:00:00 +0000 BioSpace.com Featured News tag:rss.biospace.com://140719cfca2ea3a1dabe3c949d5ee6ef http://www.biospace.com/news_story.aspx?StoryID=148593&full=1/feed/ 0 Novo Nordisk A/S — Treasury Stock http://www.biospace.com/news_story.aspx?StoryID=148582&full=1 http://www.biospace.com/news_story.aspx?StoryID=148582&full=1#comments Wed, 01 Jul 2009 00:00:00 +0000 BioSpace.com Featured News tag:rss.biospace.com://3abeecf968f131e3021ce82155d7b1cf

BAGSVAERD, DENMARK--(Marketwire - July 01, 2009) - Status regarding Novo Nordisk's holdingof its own shares (30 June2009)


In continuation of the company's announcement dated 29 January 2009concerning a planned share repurchase programme, and pursuant toSection 204.25 of the New York Stock Exchange Listed Company Manual,this is to report that Novo...]]> http://www.biospace.com/news_story.aspx?StoryID=148582&full=1/feed/ 0 Pfizer Inc. Invites Public to Listen to Teleconference on Important Update Related to Chantix(R) http://www.biospace.com/news_story.aspx?StoryID=148584&full=1 http://www.biospace.com/news_story.aspx?StoryID=148584&full=1#comments Wed, 01 Jul 2009 00:00:00 +0000 BioSpace.com Featured News tag:rss.biospace.com://bafd9c95a1ee744817cacce31d1b0da2 http://www.biospace.com/news_story.aspx?StoryID=148584&full=1/feed/ 0 Pfizer Inc. Updates CHANTIX(R) (varenicline) Labeling in the United States http://www.biospace.com/news_story.aspx?StoryID=148583&full=1 http://www.biospace.com/news_story.aspx?StoryID=148583&full=1#comments Wed, 01 Jul 2009 00:00:00 +0000 BioSpace.com Featured News tag:rss.biospace.com://e5246a17134d46561c8cc5b2c2a89d01 http://www.biospace.com/news_story.aspx?StoryID=148583&full=1/feed/ 0 Fate Therapeutics Granted Exclusive License By The Regents of the to Stem Cell Modulators for Osteo-Regeneration http://www.biospace.com/news_story.aspx?StoryID=148589&full=1 http://www.biospace.com/news_story.aspx?StoryID=148589&full=1#comments Wed, 01 Jul 2009 00:00:00 +0000 BioSpace.com Featured News tag:rss.biospace.com://9e440acb80dd06db9d5e1ab362f9eaf3 LA JOLLA, Calif., July 1 /PRNewswire/ -- Fate Therapeutics, Inc. announced today that it has acquired exclusive intellectual property rights covering small molecule compositions and methods for inducing bone formation from The Regents of the University of California. These proprietary osteogenic agents were developed by Farhad Parhami, Ph.D., professor of medicine at University of California, Los...]]> http://www.biospace.com/news_story.aspx?StoryID=148589&full=1/feed/ 0 Department of Defense Releases Further Funding to Cleveland Biolabs Inc. Under $8.8 Million Contract for Development Studies on Protectan CBLB502 http://www.biospace.com/news_story.aspx?StoryID=148531&full=1 http://www.biospace.com/news_story.aspx?StoryID=148531&full=1#comments Wed, 01 Jul 2009 00:00:00 +0000 BioSpace.com Featured News tag:rss.biospace.com://862f4c5effba4f4b0e7cd3a56aca8a9a

BUFFALO, NY--(Marketwire - July 01, 2009) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) todayannounced that the Chemical Biological Medical Systems MedicalIdentification and Treatment Systems Joint Product Management Office(CBMS-MITS JPMO) of The Department of Defense (DoD) has exercised thecontract...]]> http://www.biospace.com/news_story.aspx?StoryID=148531&full=1/feed/ 0